10 stock picks to buy now for future market recovery: Morningstar

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Business Business Headlines News

Morningstar: Buy these 10 cheap, defensive stocks to survive a rough second quarter and position for better times ahead

But Dave Sekera also says patient investors can position themselves for future success.The stock market has presented investors with an interesting dilemma in the second quarter of 2023: equities are cheap, but market conditions mean it's a difficult time to get bullish.

Sekera doesn't expect much growth for the next couple of quarters, and with a weak start to 2024 he is only projecting a 1.4.% increase in US GDP in 2024. Still, he wrote that this is an opportune moment to position for the next recovery. He explained that interest rates and inflation will come down over the next few years and growth will improve, all of which sets a solid foundation for stocks. For now, Sekera wrote, stocks are likely to stay inside their recent trading range, with positive and negative economic news dictating their course. It might not be exciting, but there will be opportunities to build future positions.

At a sector level, Sekera says small caps are trading 33% below Morningstar's estimate of their fair value, while communications stocks are still at a 30% discount in spite of a recent rally, and real estate trades at a 22% discount.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Shorts appear anxious.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Weight Watchers parent’s stock soars after deal to buy weight-loss drug prescriber Sequence closesThis deal seems to be tipping the scales in Weight Watchers’ favor, as the parent stock was soaring Tuesday morning off a deal to acquire Sequence, a weight-loss drug prescriber.
Source: MarketWatch - 🏆 3. / 97 Read more »

Goldman: Buy WeightWatchers stock on deal to offer weight-loss drugsGoldman Sachs says WeightWatchers' latest deal could revive the company and help it bring in $1.4 billion by 2025 While the media glorifies obesity. Lol nice try
Source: BusinessInsider - 🏆 729. / 51 Read more »

Bankman-Fried reportedly joked about losing track of assets worth millionsInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know. This is no joking matter, son Into his own pocket. Know where it went, no.publication dare say.
Source: BusinessInsider - 🏆 729. / 51 Read more »